Evaluation of dopamine transporter density in healthy Brazilians using Tc-99m TRODAT-1 SPECT
Open Access
- 1 October 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (39) , e27192
Abstract
The presynaptic dopamine transporter (DAT) modulates the uptake of dopamine by regulating its concentration in the central nervous system. We aimed to evaluate the DAT binding potential (DAT-BP) in a sample of healthy Brazilians through technetium-99 metastable TRODAT-1 single-photon emission computed tomography imaging. We selected 126 healthy individuals comprising 72 men and 54 women, aged 18 to 80 years. We conducted semi-quantitative evaluation in transaxial slices, following which we identified the regions of interest in the striatal region using the occipital lobe as a region of non-specific DAT-BP. We found a decrease in DAT-BP in healthy individuals aged over 30 years, culminating in a 42% mean reduction after 80 years. There was no difference in the decrease by age group between the right (linear regression test [R 2] linear = 0.466) and left striatum (R 2 linear = 0.510). Women presented a higher DAT-BP than men (women: R 2 linear = 0.431; men: R 2 linear = 0.457); nonetheless, their decrease by age group was equal to that in men. Our study sheds light on important DAT-BP findings in healthy Brazilian subjects. Our results will facilitate understanding of brain illnesses that involve the dopamine system, such as neuropsychiatric disorders.Keywords
All Related Versions
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
This publication has 36 references indexed in Scilit:
- Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?—A [99mTc]‐TRODAT‐1 SPECT studyMovement Disorders, 2007
- Neuroimagem do transportador de dopamina na doença de Parkinson: primeiro estudo com [99mTc]-TRODAT-1 e SPECT no BrasilArquivos de Neuro-Psiquiatria, 2006
- Parkinson’s disease and dopamine transporter neuroimaging: a critical reviewSao Paulo Medical Journal, 2006
- Biomarkers and Parkinson's diseaseBrain, 2004
- Radiopharmaceuticals for single-photon emission computed tomography brain imagingSeminars in Nuclear Medicine, 2003
- Low Dopamine D2 Receptor Binding Potential in Social PhobiaAmerican Journal of Psychiatry, 2000
- Specificity of Diastereomers of [99mTc]TRODAT-1 as Dopamine Transporter Imaging AgentsJournal of Medicinal Chemistry, 1998
- Imaging of dopamine transporters in humans with technetium-99m TRODAT 1European Journal of Nuclear Medicine and Molecular Imaging, 1996
- Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTRGenomics, 1992
- Striatal dopamine deficiency in parkinson's disease: Role of agingAnnals of Neurology, 1989